James Engelhart
Director/Board Member at Our Lady of Mercy Academy
Profile
Mr. James Engelhart, CPA, is a Chief Financial Officer & Treasurer at Biohaven Pharmaceutical Holding Co. Ltd. He is on the Board of Directors at Our Lady of Mercy Academy. Mr. Engelhart was previously employed as an Executive Director-Finance by Alexion Pharmaceuticals, Inc., a Finance Director by Energizer SpinCo, Inc., and an Auditor by Coopers & Lybrand LLP. He received his undergraduate degree from Villanova University and an undergraduate degree from Villanova School of Business.
James Engelhart active positions
| Companies | Position | Start |
|---|---|---|
| Our Lady of Mercy Academy | Director/Board Member | - |
Former positions of James Engelhart
| Companies | Position | End |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 2021-12-14 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-04-30 |
| ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 2014-06-30 |
| Coopers & Lybrand LLP | Corporate Officer/Principal | 1990-12-31 |
Training of James Engelhart
| Villanova School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| Our Lady of Mercy Academy |
- Stock Market
- Insiders
- James Engelhart
